Country: Australia
Language: English
Source: Department of Health (Therapeutic Goods Administration)
Black snake antivenom
Nova Pharmaceuticals Australasia Pty Ltd
Medicine Registered
BLACK SNAKE ANTIVENOM 1 BLACK SNAKE ANTIVENOM CONSUMER MEDICINE INFORMATION_ _ WHAT IS IN THIS LEAFLET This leaflet answers some common questions about Black Snake Antivenom. It does not contain all the available information. It does not take the place of talking to your doctor or pharmacist. All medicines have risks and benefits. Your doctor has weighed the risks of you having Black Snake Antivenom against the benefits they expect it will have. IF YOU HAVE ANY CONCERNS ABOUT THIS MEDICINE, ASK YOUR DOCTOR, NURSE OR PHARMACIST. KEEP THIS LEAFLET. You may need to read it again. WHAT BLACK SNAKE ANTIVENOM IS USED FOR _WHAT IT IS USED FOR _ Black Snake Antivenom is given to those people who become ill after being bitten by a king brown snake or mulga snake. The antivenom is also effective if you have been bitten by a black snake but Tiger Snake Antivenom is usually used for treating black snake bites as it is just as effective but is a smaller injection. Not everyone who is bitten needs the antivenom as some people have only very mild effects from the bite or none at all. However, some people can become very ill after being bitten and in these people it is essential to use an appropriate amount of antivenom to counteract the effects of the poison. _HOW IT WORKS _ Black Snake Antivenom is an injection designed to help neutralise the effect of the poison (venom) of the king brown snake (mulga). It is made by immunising horses against the venom of the king brown snake and then collecting that part of the horse’s blood which neutralises this poison. The Read the complete document
BLACK SNAKE ANTIVENOM PRODUCT INFORMATION 1(4) PRODUCT INFORMATION NAME OF THE MEDICINE BLACK SNAKE ANTIVENOM AUST R 74894 DESCRIPTION BLACK SNAKE ANTIVENOM is prepared from the plasma of horses immunised with the venom of the king brown snake (_Pseudechis australis_) also known as the mulga snake. The king brown snake is a member of the genus _Pseudechis_, known as black snakes. Each vial contains 18,000 units of antivenom which has been standardised to neutralise _in vitro_ the average yield of venom from the king brown snake. The product also contains phenol, sodium chloride and other equine plasma proteins in an aqueous solution. PHARMACOLOGY The venom of the king brown snake contains neurotoxins, myolytic toxins and an anticoagulant toxin but does not cause afibrinogenaemic coagulopathy as happens with most other Australian snake venoms. The venom is less toxic for laboratory animals than that of most other Australian snakes but the volume of venom is often greater. Although BLACK SNAKE ANTIVENOM is effective against other members of the genus _Pseudechis_, including the red-bellied or common black snake, Tiger Snake Antivenom is usually the preferred treatment. Tiger Snake Antivenom is equally effective whilst the volume of injection and the amount of equine protein are less than with BLACK SNAKE ANTIVENOM (see PRECAUTIONS). INDICATIONS For the treatment of patients who exhibit manifestations of systemic envenoming following a bite by a king brown or mulga snake. Although the antivenom is effective in the management of patients who are bitten by other members of the genus _Pseudechis_, including the red-bellied or common black snake, Tiger Snake Antivenom is the preferred treatment (see PHARMACOLOGY). CONTRAINDICATIONS There are no absolute contraindications, but the product should not be used unless there is clear evidence of sy Read the complete document